You are here
Raffles Medical Q2 profit drops 15.6% on startup costs for Chongqing hospital
INTEGRATED healthcare provider Raffles Medical Group on Monday morning posted a 15.6 per cent fall in net profit to S$14.2 million for its second quarter ended June 30, down from S$16.9 million in the year-ago period, due to startup costs at its Chongqing hospital.
Revenue for the quarter grew 5.6 per cent from a year ago to S$127 million, amid an increase in contributions from the healthcare services and hospital services division by 7.4 per cent and 3.4 per cent respectively.
The higher revenue from healthcare services was a result of winning more insurance contracts and corporate clients, while the higher revenue from hospital services was due to patient growth.
Earnings per share was 0.79 Singapore cents for the quarter, down from 0.95 cents a year ago.
The board has declared a dividend of 0.5 Singapore cent per share for the quarter, the same as last year.
Gestation losses at Raffles Hospital Chongqing – around S$2.3 million at the earnings before interest, taxes, depreciation and amortisation (Ebitda) level – contributed to the drop in Q2 net profit.
The group said on Monday that the Chongqing hospital was developed “well within the budgeted costs”, and its operating costs for the first six months were “significantly lower” than expected.
Raffles Hospital Chongqing’s management is making “great efforts” to reach out to corporate and private patients of Chongqing, the group added. Since it opened on Jan 2, 2019, the hospital is now operating 24/7.
Previously, the group’s first-quarter net profit had also fallen due to startup costs at the hospital. Net profit for the three months to March 31 slipped 13.7 per cent to S$13.6 million.
Excluding the Chongqing hospital’s results, net profit after tax for Q2 would have increased by 0.4 per cent instead of the 15.6 per cent drop, said the company.
The group said it is expected to remain profitable in 2019 despite the gestation losses for Raffles Hospital Chongqing.
For the half year ended June 30, net profit shrank 14.7 per cent to S$27.9 million, while revenue gained 6.2 per cent to S$255.3 million.
Shares of Raffles Medical closed at S$1.03 on Friday, up one cent or 0.98 per cent.